SEC Form 4 · accession 0001179110-15-006207
MERRIMACK PHARMACEUTICALS INC · MACK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary L Crocker
Director
Period of report
Apr 2, 2015
Accepted (ET)
Apr 10, 2015 · 9:41 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001274792
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 2, 2015 | M | 35,000 | $1.71 | A | 2,893,961 | D | |
| Common Stock | Apr 2, 2015 | M | 50,000 | $2.47 | A | 2,943,961 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.71 | Apr 2, 2015 | M | 35,000 | D | — | Aug 3, 2015 | Common Stock | 35,000 | 0 | D |
| Stock Option (right to buy)F1 | $2.47 | Apr 2, 2015 | M | 50,000 | D | — | Aug 1, 2016 | Common Stock | 50,000 | 0 | D |
Explanation of responses
- F1This option is fully vested.